ThinShins: Just to repeat what I was told by Dr Stacey Adam: "There is a new inpatient platform protocol called, STRIVE, that is targeted for activation in mid-summer, pending regulatory review"
No, it isn't us. On 9th June she wrote in an email to me: "The ACTIV-2 trial only has one arm that could still re-open and that is the arm with the Shionogi oral protease inhibitor that is currently on hold pending FDA review."
It would be only the Pfizer/Biontech and Moderna vaccines. AZ is not mRNA. I too regret having the Pfizer booster, but have suffered with blood clots and pulmonary embolisms since the earlier AZ jabs. So I am naturally sceptical of them all! Clearly there is a long way to go before the science is fully understood.